Market Capitalization & Enterprise Value
Research-grade valuation history for BIOIF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.
Market Cap & Enterprise Value
Comparison of market capitalization and enterprise value over time
Market Cap
Enterprise Value
Market Cap History
Investor Valuation Insights
As of Sep 30, 2023EV/EBITDA
-193.12x
Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.
EV vs Market Cap Spread
4.05M
EV is +289.4% vs equity value
Capital Structure Signal
Net Debt Profile
Trend unavailable for selected history
Additional Multiples
EV/Sales: 0.00x
Net Debt/EBITDA: -170.57x
Share count trend unavailable
Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.
Market Cap & Enterprise Value Data
Free users can view the latest 3 records. Upgrade to see full history.
| Date | Market Cap | Enterprise Value | Stock Price | Shares |
|---|---|---|---|---|
| Dec 31, 2022 | 1.40M | 5.45M | $0.01 | 112.42M |
| Dec 31, 2021 | 3.65M | 6.57M | $0.03 | 112.42M |
| Dec 31, 2020 | 4.90M | 8.50M | $0.04 | 111.89M |
Dec 31, 2019 | — | — | — | — |
Dec 31, 2018 | — | — | — | — |
Dec 31, 2017 | — | — | — | — |
Dec 31, 2016 | — | — | — | — |
Dec 31, 2015 | — | — | — | — |
Dec 31, 2014 | — | — | — | — |
Dec 31, 2013 | — | — | — | — |